[SCENARIO] id=107 | sector=health | agents=3 | rounds=20
[AGENTS] 1=Quality & Patient Safety Director, 2=Pharmacy Informatics Lead, 3=Hospital Finance & Operations Director
[GOAL] Produce a final recommendation on whether to approve and fund a 60-day corrective action plan to raise inpatient medication reconciliation reliability at admission and discharge, balancing regulatory deadlines, patient-safety impact, workflow feasibility, and financial/operational constraints.

[R0.1] Quality & Patient Safety Director (speak, public): I would like to discuss the corrective action plan for improving inpatient medication reconciliation. We need to ensure that it aligns with the Joint Commission's requirements, especially considering the compliance audit results we have on hand. Currently, the admission med reconciliation is at 71% and discharge at 62%. Given the top contributors to defects, particularly the unclear ownership and after-hours admissions, can we explore how to improve these areas effectively without disrupting current workflows?
[R0.2] Pharmacy Informatics Lead (speak, public): To improve the medication reconciliation process, we can implement a discharge hard-stop for 'Reconcile and Sign' in the EHR, which should help clarify ownership during critical transitions. This change is estimated to take about 120 hours to build and will require a two-week testing cycle before rollout. Additionally, we can develop a microlearning training module that is 15 minutes long, aimed at our target audience of 850 learners, to support the new workflow. What are your thoughts on this approach?
[R0.3] Hospital Finance & Operations Director (speak, public): The proposed changes seem promising, especially the discharge hard-stop for 'Reconcile and Sign.' However, I’d like to better understand the financial implications. Can you provide an estimate of the cost associated with the 120 hours of build time and the training module development? Also, how do you foresee these changes impacting our current workflow and resource allocation?

[R1.1] Quality & Patient Safety Director (speak, public): I appreciate the detailed proposal regarding the discharge hard-stop and the microlearning training module. It's crucial that we balance the implementation with our financial constraints. I suggest we conduct a cost analysis on the estimated 120 hours of build time and the training module. Additionally, it would be beneficial to outline how these changes can be integrated into our current workflows without causing significant disruptions. Can we work together to gather this cost data and assess the overall impact on our resources?
[R1.2] Pharmacy Informatics Lead (speak, public): To provide a preliminary cost estimate, the build time for the EHR change at 120 hours would likely approximate $10,000, considering our standard hourly rates. The microlearning training module may cost around $5,000 to develop, given the content creation and platform integration. I believe these changes can be integrated into our workflows with minimal disruption, though close collaboration will be essential to ensure a smooth transition. Shall we consider scheduling a follow-up meeting to dive deeper into the cost analysis and workflow integration?
[R1.3] Hospital Finance & Operations Director (speak, public): Thank you for the preliminary cost estimates. Based on the projected costs of $10,000 for the EHR changes and $5,000 for the training module, which totals $15,000, we should assess how this fits within our overall budget for this fiscal year. I suggest we gather a detailed breakdown of these costs and evaluate potential funding sources. Additionally, it would be beneficial to analyze the long-term impact on preventable ADEs, given that each one costs approximately $3,200. Let's schedule a follow-up meeting to finalize our analysis and ensure alignment with our operational goals.

[R2.1] Quality & Patient Safety Director (leave, public): 
[R2.2] Pharmacy Informatics Lead (leave, public): 
[R2.3] Hospital Finance & Operations Director (leave, public): 

[R3.1] Quality & Patient Safety Director (leave, public): 
[R3.2] Pharmacy Informatics Lead (leave, public): 
[R3.3] Hospital Finance & Operations Director (leave, public): 

[R4.1] Quality & Patient Safety Director (leave, public): 
[R4.2] Pharmacy Informatics Lead (leave, public): 
[R4.3] Hospital Finance & Operations Director (leave, public): 

[R5.1] Quality & Patient Safety Director (leave, public): 
[R5.2] Pharmacy Informatics Lead (leave, public): 
[R5.3] Hospital Finance & Operations Director (leave, public): 

[R6.1] Quality & Patient Safety Director (leave, public): 
[R6.2] Pharmacy Informatics Lead (leave, public): 
[R6.3] Hospital Finance & Operations Director (leave, public): 

[R7.1] Quality & Patient Safety Director (leave, public): 
[R7.2] Pharmacy Informatics Lead (leave, public): 
[R7.3] Hospital Finance & Operations Director (leave, public): 

[R8.1] Quality & Patient Safety Director (leave, public): 
[R8.2] Pharmacy Informatics Lead (leave, public): 
[R8.3] Hospital Finance & Operations Director (leave, public): 

[R9.1] Quality & Patient Safety Director (leave, public): 
[R9.2] Pharmacy Informatics Lead (leave, public): 
[R9.3] Hospital Finance & Operations Director (leave, public): 

[R10.1] Quality & Patient Safety Director (leave, public): 
[R10.2] Pharmacy Informatics Lead (leave, public): 
[R10.3] Hospital Finance & Operations Director (leave, public): 

[R11.1] Quality & Patient Safety Director (leave, public): 
[R11.2] Pharmacy Informatics Lead (leave, public): 
[R11.3] Hospital Finance & Operations Director (leave, public): 

[R12.1] Quality & Patient Safety Director (leave, public): 
[R12.2] Pharmacy Informatics Lead (leave, public): 
[R12.3] Hospital Finance & Operations Director (leave, public): 

[R13.1] Quality & Patient Safety Director (leave, public): 
[R13.2] Pharmacy Informatics Lead (leave, public): 
[R13.3] Hospital Finance & Operations Director (leave, public): 

[R14.1] Quality & Patient Safety Director (leave, public): 
[R14.2] Pharmacy Informatics Lead (leave, public): 
[R14.3] Hospital Finance & Operations Director (leave, public): 

[R15.1] Quality & Patient Safety Director (leave, public): 
[R15.2] Pharmacy Informatics Lead (leave, public): 
[R15.3] Hospital Finance & Operations Director (leave, public): 

[R16.1] Quality & Patient Safety Director (leave, public): 
[R16.2] Pharmacy Informatics Lead (leave, public): 
[R16.3] Hospital Finance & Operations Director (leave, public): 

[R17.1] Quality & Patient Safety Director (leave, public): 
[R17.2] Pharmacy Informatics Lead (leave, public): 
[R17.3] Hospital Finance & Operations Director (leave, public): 

[R18.1] Quality & Patient Safety Director (leave, public): 
[R18.2] Pharmacy Informatics Lead (leave, public): 
[R18.3] Hospital Finance & Operations Director (leave, public): 

[R19.1] Quality & Patient Safety Director (leave, public): 
[R19.2] Pharmacy Informatics Lead (leave, public): 
[R19.3] Hospital Finance & Operations Director (leave, public): 

